Christina Wurster: Chief Executive Officer
Washington, DC – Christina Wurster, a global medical society executive, has been selected as Chief Executive Officer of the Society for Maternal-Fetal Medicine, an organization providing education, promoting research, and engaging in advocacy to optimize the health of those with high-risk pregnancies and their babies. Wurster brings more than 20 years of experience in strategic planning, program development, communications, and stakeholder relations to this role.
Most recently, Wurster has been Chief Strategy Officer of the Heart Rhythm Society, an international leader in science, education, and advocacy for cardiac arrhythmia professionals and patients. As a senior member of the executive team, she directed revenue generation, membership, global and strategic partnerships, publications, digital health, and strategic planning for this thriving 7,200-member organization.
During her tenure, Wurster developed innovative partnerships that have resulted in increased revenue and diversified income-producing channels which include $5.6M+ annually in grants and sponsorships, and new programs such as three start-up initiatives financed by a new-business opportunities fund. She also led the Society as it moved from supporting one to four peer-reviewed journals, including its launch of the first-in-market Cardiovascular Digital Health Journal.
Wurster has previously served the Heart Rhythm Society in a variety of executive positions Prior to the Heart Rhythm Society, Wurster was Manager of Strategic Marketing and Planning for Massachusetts General Hospital where she was the lead strategic planner and liaison to the Heart and Vascular Centers.
With more than 5,000 member physicians, scientists, and women's health professionals around the world, the Society for Maternal -Fetal Medicine supports the clinical practice of maternal-fetal medicine by providing education, promoting research, and engaging in advocacy to optimize the health of high-risk pregnant women and their babies.
